Abstract
Janus kinases (JAKs) are considered promising targets for the treatment of autoimmune diseases including rheumatoid arthritis (RA) due to their important role in multiple cytokine receptor signaling pathways. Recently, several JAK inhibitors have been developed for the treatment of RA. Here, we describe the identification of the novel orally bioavailable JAK inhibitor 18, peficitinib (also known as ASP015K), which showed moderate selectivity for JAK3 over JAK1, JAK2, and TYK2 in enzyme assays. Chemical modification at the C4-position of lead compound 5 led to a large increase in JAK inhibitory activity and metabolic stability in liver microsomes. Furthermore, we determined the crystal structures of JAK1, JAK2, JAK3, and TYK2 in a complex with peficitinib, and revealed that the 1H-pyrrolo[2,3-b]pyridine-5-carboxamide scaffold of peficitinib forms triple hydrogen bonds with the hinge region. Interestingly, the binding modes of peficitinib in the ATP-binding pockets differed among JAK1, JAK2, JAK3, and TYK2. WaterMap analysis of the crystal structures suggests that unfavorable water molecules are the likely reason for the difference in orientation of the 1H-pyrrolo[2,3-b]pyridine-5-carboxamide scaffold to the hinge region among JAKs.
Citations
Nov 19, 2019·Expert Opinion on Investigational Drugs·Jing WuChanghai Ding
Apr 11, 2020·Clinical Drug Investigation·Mai ShibataTetsuya Nishimura
Apr 30, 2020·Expert Opinion on Pharmacotherapy·Yoshiya Tanaka, Hiroyuki Izutsu
Jun 6, 2020·Immunological Medicine·Akio Morinobu
Nov 26, 2019·Rheumatology·Yukihiro KitanagaYoshiya Tanaka
Dec 28, 2019·Journal of Crohn's & Colitis·Marc Ferrante, João Sabino
Jul 10, 2020·Modern Rheumatology·Yuko Kaneko
Sep 30, 2019·Topics in Current Chemistry·Shiyang ZhouGangliang Huang
Dec 14, 2019·Clinical Pharmacology in Drug Development·Daisuke MiyatakeAkinori Urae
Mar 14, 2020·Arthritis Research & Therapy·Tsutomu TakeuchiEmi Yamada
Mar 16, 2019·Pharmaceuticals·Annie Mayence, Jean Jacques Vanden Eynde
Jun 13, 2020·Frontiers in Molecular Biosciences·Jingyu ZhuJian Jin
May 7, 2019·Expert Review of Clinical Pharmacology·Qian QiuMingxing Guo
May 23, 2020·Clinical and Experimental Gastroenterology·Edoardo TronconeGiovanni Monteleone
Mar 18, 2020·Zeitschrift für Rheumatologie·Stephan Blüml
Aug 15, 2019·Rheumatology and Therapy·Mark C GenoveseAlan J Kivitz
Dec 8, 2020·Chemico-biological Interactions·Iza Mirela Rodini Garcia-PrincivalTeresinha Gonçalves da Silva
Feb 18, 2021·Journal of Medicinal Chemistry·Chufeng ZhangLijuan Chen
Mar 21, 2021·Inflammatory Bowel Diseases·Isabel GarridoGuilherme Macedo
Mar 31, 2021·Journal of Medicinal Chemistry·Andrew C FlickChristopher J O'Donnell
Apr 29, 2021·Journal of Agricultural and Food Chemistry·Yu-Meng ZhangYu-Qing Zhao
Nov 25, 2020·Organic Letters·Junheng LiuJiangtao Sun
Oct 9, 2021·Journal of Medicinal Chemistry·Cecilia C Ayala-AguileraAsier Unciti-Broceta
Dec 24, 2021·Chemical Biology & Drug Design·Shiyang Zhou, Gangliang Huang
Jul 3, 2021·Journal of Medicinal Chemistry·Stanislav AndreevPierre Koch